News

03.04.2018

“A good network is power”

“A good network is power”

Melanie Kovacs was frustrated by the IT teaching she got, and developed her own product – Master21. She attributes her success with this not least to her carefully maintained network, which has continued to grow in Basel. Melanie Kovacs and her fellow campaigners use the technology and innovation network “We Shape Tech” to promote diversity by making women working in the technology and innovation field more visible.

mehr >
17.04.2018

Basel researchers cultivate cartilage from stem cells

Basel researchers cultivate cartilage from stem cells

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem cells usually develop into cartilage tissue which later naturally remodels into bone tissue. Even if the stem cells are induced to differentiate into cartilage cells, they spontaneously mature into a so-called “hypertrophic” state, ultimately leading to the formation of bone tissue; this is similar to the cartilaginous tissue temporarily formed after a fracture.

mehr >
17.04.2018

Coop to acquire Siroop

Coop to acquire Siroop

Coop will acquire Swisscom’s 50 per cent share package in Siroop. As a result, the jointly launched Zurich-based online marketplace will soon be wholly owned by the retail cooperative, which plans to consolidate Siroop with its own Microspot sales channel.

mehr >
28.03.2018

Die Wirtschaftsregion Basel-Jura entwickelt sich stabil

Die Wirtschaftsregion Basel-Jura entwickelt sich stabil

Die Wirtschaftsregion Basel-Jura bietet Unternehmen ein erstklassiges Umfeld. Dies das Fazit des aktuellen Jahresberichts 2017 von BaselArea.swiss.

mehr >
16.04.2018

Straumann invests in artificial intelligence

Straumann invests in artificial intelligence

Basel-based dental technology company Straumann is investing in French company Dental Monitoring. Its innovative remote monitoring system strengthens Straumann use of artificial intelligence.

mehr >
13.04.2018

Digital Nudges in healthcare - still to be explored

Digital Nudges in healthcare - still to be explored

The bad news: If anyone expected that Behavioral Sciences will soon lead to a nudge strategy to solve every one of Healthcare’s problems then they were disappointed at the DayOne Experts Event, taking place on April 11. Academia and industry are still at an early stage in understanding and applying techniques to change behaviors.

mehr >
13.03.2018

“I enjoy thinking about seemingly unsolvable problems”

“I enjoy thinking about seemingly unsolvable problems”

Andreas Plückthun continues his research where others stop: 40 employees work in his laboratory on protein engineering. Their results form the basis for three biotech companies: Morphosys in Munich, as well as Molecular Partners and G7 Therapeutics (today Heptares Zurich) in Schlieren. At the Antibody Congress 2017 in Basel, Andreas Plückthun told us why he remains true to his research.

mehr >
12.04.2018

Borders & Frontiers at TEDx Basel conference

Borders & Frontiers at TEDx Basel conference

Taking place at Musical Theatre on May 26 2018, the theme of the 4th annual TEDxBasel conference will be Borders & Frontiers and will feature 10 inspiring speakers and talented performers with Ideas Worth Spreading from the fields of Design, Science, Sports, Technology, Leadership and more.

mehr >
12.04.2018

Roivant launches new subsidiary in Basel

Roivant launches new subsidiary in Basel

Roivant Sciences, a pharmaceutical company based in Basel, is launching Genevant with the Canadian Arbutus Biopharma Corporation. The aim of the new jointly-owned company is to develop therapeutics for genetic diseases.

mehr >
11.03.2018

Meet the BaseLaunch Startups

Meet the BaseLaunch Startups

Six of the BaseLaunch startups recently started Phase II. They received either grants up to 250,000 Swiss francs or gained free of charge access to BaseLaunch laboratory and office space at the Switzerland Innovation Park Basel Area. Hear what the startups, the BaseLaunch team and selection committee members experienced in the first year. Find out more about what makes BaseLaunch unique.

mehr >
12.04.2018

Millions of EU funding for two researchers from the University of Basel

Millions of EU funding for two researchers from the University of Basel

Two scientists from the University of Basel have been awarded the prestigious ERC Advanced Grants by the European Research Council (ERC): Neuroscientist Prof. Fiona Doetsch and physicist Prof. Christian Schönenberger each receive 2.5 million euros of funding. Christian Schönenberger is one of the few scientists whose groundbreaking research has received an ERC Advanced Grant for the second time.

mehr >
11.04.2018

Connecting Innovators App Launch

Connecting Innovators App Launch

How the BaselArea.swiss-App connects innovators and supports an innovative idea.

mehr >
06.02.2018

“As an entrepreneur, you have to own up to your decisions”

“As an entrepreneur, you have to own up to your decisions”

Five years ago, Alisée de Tonnac quit her job at L’Oréal and travelled the world to set up the first edition of the startup competition Seedstars World. Five years later, Seedstars is present in more than 85 cities worldwide, runs its own co-working and educational centers and plans to have 15 Seedspaces for co-working and co-living by the end of 2018. BaselArea.swiss sat down with Alisée de Tonnac after her keynote at the Swiss Innovation Forum that took place in Basel last November.

mehr >
10.04.2018

Novartis to acquire gene therapy specialist

Novartis to acquire gene therapy specialist

Novartis announced that it will acquire AveXis for $8.7 billion. The US-based specialist for gene therapies developed a therapy for spinal muscular atrophy, which is expected to be launched on the market in 2019. AveXis also operates a gene therapy platform that is scalable for other diseases.

mehr >
09.04.2018

Polyphor plans to go public

Polyphor plans to go public

Biopharmaceutical company Polyphor intends to conduct an initial public offering (IPO) on the SIX Swiss Exchange in the second quarter of 2018. The offering is expected to be in the range of 100 million to 150 million Swiss francs.

mehr >
09.01.2018

"We're giving Basel Impact Hub fever"

Impact Hubs are a real success story. Founded in 2005 in London, there are now over 100 Impact Hubs around the world with more than 15,000 members. Following the lead from Bern, Zurich, Geneva and Lausanne, Basel will be the next Impact Hub in Switzerland. The force behind the movement is Hubbasel, an association founded by entrepreneur André Moeri, sustainability expert Connie Low and lawyer Hanna Byland. We wanted to know why an Impact Hub is more than just a coworking space and how entrepreneurs as well as investors and companies benefit from them, so we talked with Hanna Byland to shed some light for us.

mehr >
05.04.2018

Blockchain in der Praxis

Blockchain in der Praxis

Die Blockchain-Technologie wird als Innovation des Jahrzehnts gehandelt. Erstmals ist es möglich Besitzverhältnisse von virtuellem Eigentum eindeutig festzuhalten und zu handeln, ohne dass dafür eine zentrale Instanz benötigt wird – eine Entwicklung, die das Potenzial hat, die bestehende Zahlungsinfrastruktur und das Finanzsystem grundlegend zu verändern. Hinzu kommen die noch nicht absehbaren Möglichkeiten von Smart Contracts, dezentralen Applikationen (DAPPs) und dezentralen Organisationen (DAOs).

mehr >
05.04.2018

Basel allocates space for new head offices

Basel allocates space for new head offices

The Basel local government is designating the Rosental areal for high value-added sectors. The aim is to attract head offices of international companies, high-value services and research facilities.

mehr >
04.12.2017

“Precision medicine is the best opportunity to reconfigure healthcare”

“Precision medicine is the best opportunity to reconfigure healthcare”

After 20 years with the pharmaceutical company Eli Lilly, Bernard Munos set out to better understand pharmaceutical innovation – specifically what makes it possible and how to get more of it. Munos is now a Senior Fellow at Faster Cures, a Center of the Milken Institute, and the founder of the consultancy InnoThink, which advises biomedical research organizations on how to become better innovators. He also contributes to Forbes magazine, an American business publication. Munos travelled to Basel in October, on behalf of HKBB and DayOne to participate in the “Powertalk”.

mehr >
04.04.2018

Talk to a doctor via new Medgate app

Talk to a doctor via new Medgate app

The telemedicine company Medgate has developed a new app. This enables users to make a telemedical doctor’s appointment even at short notice. As a new feature, the consultation can now also be via video on the smartphone.

mehr >
03.04.2018

Industrie 4.0 am südlichen Oberrhein

Industrie 4.0 am südlichen Oberrhein

Die Region südlicher Oberrhein vom Elsass über Karlsruhe bis in den Aargau ist durch eine hohe Industrialisierung mit vielen erfolgreichen KMU geprägt. Damit die Region auch weiterhin wirtschaftlich attraktiv bleibt, muss sie sich den Herausforderungen der Digitalisierung stellen: sich verändernde Arbeitsmarktbedingungen, neue Geschäftsmodelle oder Beschleunigung der Innovationen sind einige der Schwierigkeiten.

mehr >
06.11.2017

“We want to improve the visibility of startups at the University of Basel”

“We want to improve the visibility of startups at the University of Basel”

Christian Elias Schneider has been Head of Innovation at the University of Basel for eight months now. His job is to promote entrepreneurship and projects in collaboration with industry.

mehr >
02.04.2018

Speed Dating 4.0 in Gaggenau

Speed Dating 4.0 in Gaggenau

Am 12. März 2018 trafen sich Vertreter von KMUs und Unternehmer aus Frankreich, Deutschland und der Schweiz zur Trinationalen Industrie 4.0 Konferenz des Expertenausschusses Innovationsförderung der Oberrheinkonferenz, der Wirtschaftsregion Mittelbaden, Daimler und für die Schweiz BaselArea.swiss für KMUs in Gaggenau.

mehr >
29.03.2018

Innosuisse Roadshow in Basel – new team, fundings and open questions

Innosuisse Roadshow in Basel – new team, fundings and open questions

200 people wanted to learn more about Innosuisse, the successor organization of the former Commission for Technology and Innovation (CTI) and joined the event at the University of Basel, on March 22nd. The top-class event was introduced by the president of the University of Basel, Andrea Schenker-Wicki, who emphasized its impact on society and introduced two members of the Innosuisse Executive Committee, Annalise Eggimann and Dominique Gruhl-Bégin as well as Trudi Hämmerli of the Board.

mehr >
03.10.2017

"You should always have something crazy cooking on the back burner"

When Jennifer Doudna gave her keynote at Basel Life in September, the auditorium in the Congress Center was packed. Susan Gasser, Professor of Molecular Biology at the University of Basel introduced Doudna as groundbreaking and extremely innovative. The Professor of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley was on top of Gassers wish list for the Basel Life. The leading figure of what is known as the CRISPR revolution among scientists sat down with BaselArea.swiss during her stay in Basel to talk about her lab, flexible career paths and what makes a great researcher.

mehr >
29.03.2018

Non-dilutive fundings – great offers of Innosuisse and European Programs

Christof Klöpper @ Innosuisse Roadshow

A haunting question for a startup or an SME is: “How do we receive money for our R&D project – for free?” Well, everything has its prize, but it makes quite a difference if a Venture Capitalist requires ownership, i.e. shares, for capital or if research grants provide so-called non-dilutive fundings and keep the ownership untouched.

mehr >
29.03.2018

Clinerion appoints new CEO

Clinerion appoints new CEO

In April, Ian Rentsch will take over as CEO of Clinerion, a Basel-based startup that runs a platform for recruiting patients for clinical trials. Rentsch sees major potential for Clinerion and will lead the startup’s global expansion.

mehr >
29.09.2017

Spirochem opens new state-­of-­the-­art Services and R&D facilities in Basel

Spirochem opens new state-­of-­the-­art Services and R&D facilities in Basel

Basel – The fine chemicals company SpiroChem has relocated to state-of-the-art facilities in the Rosental area of Basel, offering the company an ideal location to significantly expand its operations. SpiroChem has also strengthened its board of directors.

mehr >
23.03.2018

Basel has top transport infrastructure

Basel has top transport infrastructure

Basel has secured 13th place overall in a PwC ranking, but it notched up second position for transport systems and infrastructure. It also performed well for cost of living.

mehr >
22.03.2018

Basel scientists make cancer breakthrough

Basel scientists make cancer breakthrough

A team of researchers led by University of Basel professor Michael N. Hall has discovered a new anti-cancer protein. The presence of the protein's genetic information in mice prevented the formation of tumors.

mehr >
18.09.2017

13 startup projects qualify for the first phase of BaseLaunch

13 startup projects qualify for the first phase of BaseLaunch

The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were received from more than 30 countries, and the selection committee has selected 13 projects to go on to Phase I. Now, the project teams will work with industry experts to further develop their business case over the next three months.

mehr >
22.03.2018

swiss made software: Mehr als 500 Mitglieder zum 10. Jubiläum

swiss made software: Mehr als 500 Mitglieder zum 10. Jubiläum

swiss made software hat 2017 einen Meilenstein passiert: Mehr als 500 Unternehmen tragen jetzt das Prädikat «Swiss Made» und bieten mittlerweile mehr als 660 Produkte und Dienstleistungen auf www.swissmadesoftware.org an. Dies entspricht etwa 10‘000 Angestellten in der ICT-Kernbranche.

mehr >
20.03.2018

Basel scores tenth place in quality of living ranking

Basel scores tenth place in quality of living ranking

Basel among the ten cities with the highest quality of living in the world, according to a survey from the consultancy group Mercer. The city ranking can help companies decide where to open a new office.

mehr >
05.09.2017

"In Switzerland, we often sell promising technologies too early"

Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up companies that have gone on to become firmly established in the market. In 2012, he joined Clinerion as CEO and shareholder. Since then, the company has positioned itself in the medical data field and recently entered into a partnership with British company Cisiv. Clinerion's software helps recruit patients for clinical trials run by major pharmaceutical companies – in real time. But the competition never sleeps. A growing number of competitors is now appearing, especially in the USA where there is no shortage of risk capital. In this interview for the Innovation Report, Claesson explains how the Basel-based healthtech company plans to maintain its leadership position.

mehr >
19.03.2018

Fibre optic network boosts Basel’s appeal

Fibre optic network boosts Basel’s appeal

Energy and communications firm IWB and Swisscom have installed a comprehensive fibre optic network in Basel, offering clear benefits to companies located in Basel. Seven companies use the IWB and Swisscom fibre optic network to offer their services in areas such as telephony, internet and location networking, according to an IWB statement. 

mehr >
19.03.2018

Technologiepark Basel verdoppelt seine Fläche

Technologiepark Basel verdoppelt seine Fläche

Der Technologiepark Basel ist um rund 3000 Quadratmeter gewachsen. Die Erweiterung umfasst unter anderem zwölf neue Biologie- sowie zwei Chemielabors. Ausserdem wird mehr Platz für innovative Jungfirmen geschaffen.

mehr >
04.07.2017

"I want to turn innovative research into new drugs"

Cellestia CEO Michael Bauer.

Each year some 250,000 patients develop a type of cancer because of faulty communication between cells. This malfunction occurs in what is known as the NOTCH signal path. There are currently no effective treatments – but this is set to change. Cellestia Biotech AG is developing an innovative drug against this type of cancer by using a novel active ingredient that selectively attacks the malfunctioning cell communication. The drug could be used to treat leukaemia, lymphomas and solid tumours such as breast cancer.

mehr >
15.03.2018

More expats at Basel’s schools

More expats at Basel’s schools

Expat families are staying in Basel longer and longer. State schools are now responding to this trend, it was reported. For example, they are expanding the special courses in German being offered.

mehr >
14.03.2018

Branch of Innovation Park in Jura

Last year, the Economic Promotion of the Canton of Jura supported 40 companies, which will potentially create up to 264 jobs in the medium term. The canton is also opening a branch of the Switzerland Innovation Park BaselArea.

mehr >
13.06.2017

Roivant is creating a buzz in Basel

Roivant is creating a buzz in Basel

Roivant Sciences, a fast-growing life sciences company from the US, recently opened its global headquarters in Basel. In celebration of their newly established location, Roivant, together with BaselArea.swiss, invited stakeholders from the life sciences sector to “Halle 7, Gundeldingerfeld” in Basel on June 8th 2017 for a panel discussion on the future of healthcare.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)